Novel Photo-STING Agonists Delivered by Erythrocyte Efferocytosis-Mimicking Pattern to Repolarize Tumor-Associated Macrophages for Boosting Anticancer Immunotherapy

© 2024 Wiley‐VCH GmbH.

Bibliographische Detailangaben
Veröffentlicht in:Advanced materials (Deerfield Beach, Fla.). - 1998. - (2024) vom: 08. Okt., Seite e2410937
1. Verfasser: Li, Zhiyan (VerfasserIn)
Weitere Verfasser: Li, Xianghui, Lu, Yanjun, Zhu, Xudong, Zheng, Wenxuan, Chen, Kai, Wang, Xingzhou, Wang, Tao, Guan, Wenxian, Su, Zhi, Liu, Song, Wu, Jinhui
Format: Online-Aufsatz
Sprache:English
Veröffentlicht: 2024
Zugriff auf das übergeordnete Werk:Advanced materials (Deerfield Beach, Fla.)
Schlagworte:Journal Article cGAS‐STING signaling pathway immunotherapy manganese nanomedicine reactive oxygen species
LEADER 01000naa a22002652 4500
001 NLM378669206
003 DE-627
005 20241009232716.0
007 cr uuu---uuuuu
008 241009s2024 xx |||||o 00| ||eng c
024 7 |a 10.1002/adma.202410937  |2 doi 
028 5 2 |a pubmed24n1562.xml 
035 |a (DE-627)NLM378669206 
035 |a (NLM)39380354 
040 |a DE-627  |b ger  |c DE-627  |e rakwb 
041 |a eng 
100 1 |a Li, Zhiyan  |e verfasserin  |4 aut 
245 1 0 |a Novel Photo-STING Agonists Delivered by Erythrocyte Efferocytosis-Mimicking Pattern to Repolarize Tumor-Associated Macrophages for Boosting Anticancer Immunotherapy 
264 1 |c 2024 
336 |a Text  |b txt  |2 rdacontent 
337 |a ƒaComputermedien  |b c  |2 rdamedia 
338 |a ƒa Online-Ressource  |b cr  |2 rdacarrier 
500 |a Date Revised 09.10.2024 
500 |a published: Print-Electronic 
500 |a Citation Status Publisher 
520 |a © 2024 Wiley‐VCH GmbH. 
520 |a Immunotherapy has emerged as a highly effective therapeutic strategy for cancer treatment. Cyclic guanosine monophosphate-adenosine monophosphate synthase (cGAS)-stimulator of interferon gene (STING) pathway activation facilitates tumor-associated macrophage (TAM) polarization toward M1 phenotype, and Mn2+ are effective agents for this pathway activation. However, the high in vivo degradation rate and toxicity of Mn2+ hamper clinical application of immunotherapy. Here, this work has newly synthesized and screened manganese porphyrins for Mn2+ transport, referred to as photo-STING agonists (PSAs), and further encapsulate them into core-shell nanoparticles named RmPP-GA with dual specificity for tumor tissue and TAMs. Not only do PSAs achieve higher Mn2+ delivery efficiency compared to Mn2+, but they also generate reactive oxygen species under light exposure, promoting mitochondrial DNA release for cGAS-STING pathway activation. In Rm@PP-GA, globin and red blood cell membranes (Rm) are used for erythrocyte efferocytosis-mimicking delivery. Rm can effectively prolong the in vivo circulation period while globin enables PSAs to be taken up by TAMs via CD163 receptors. After Rm rupture mediated by perfluorohexane in nanoparticles under ultrasonication, drugs are specifically released for TAM repolarization. Further, dendritic cells mature, as well as T lymphocyte infiltrate, both of which favor tumor eradication. Therefore, cancer immunotherapy is optimized by novel PSAs delivered by erythrocyte efferocytosis-mimicking delivery pattern 
650 4 |a Journal Article 
650 4 |a cGAS‐STING signaling pathway 
650 4 |a immunotherapy 
650 4 |a manganese 
650 4 |a nanomedicine 
650 4 |a reactive oxygen species 
700 1 |a Li, Xianghui  |e verfasserin  |4 aut 
700 1 |a Lu, Yanjun  |e verfasserin  |4 aut 
700 1 |a Zhu, Xudong  |e verfasserin  |4 aut 
700 1 |a Zheng, Wenxuan  |e verfasserin  |4 aut 
700 1 |a Chen, Kai  |e verfasserin  |4 aut 
700 1 |a Wang, Xingzhou  |e verfasserin  |4 aut 
700 1 |a Wang, Tao  |e verfasserin  |4 aut 
700 1 |a Guan, Wenxian  |e verfasserin  |4 aut 
700 1 |a Su, Zhi  |e verfasserin  |4 aut 
700 1 |a Liu, Song  |e verfasserin  |4 aut 
700 1 |a Wu, Jinhui  |e verfasserin  |4 aut 
773 0 8 |i Enthalten in  |t Advanced materials (Deerfield Beach, Fla.)  |d 1998  |g (2024) vom: 08. Okt., Seite e2410937  |w (DE-627)NLM098206397  |x 1521-4095  |7 nnns 
773 1 8 |g year:2024  |g day:08  |g month:10  |g pages:e2410937 
856 4 0 |u http://dx.doi.org/10.1002/adma.202410937  |3 Volltext 
912 |a GBV_USEFLAG_A 
912 |a SYSFLAG_A 
912 |a GBV_NLM 
912 |a GBV_ILN_350 
951 |a AR 
952 |j 2024  |b 08  |c 10  |h e2410937